Chimeric Virus-Like Particles and Capsomeres Induce Similar CD8+ T Cell Responses but Differ in Capacity to Induce CD4+ T Cell Responses and Antibody Responses

Concentration and avidity of antibodies to different circumsporozoite epitopes correlate with RTS,S/AS01E malaria vaccine efficacy

(2019) Carlota Dobaño et al.   Nature Communications

Chimeric Murine Polyomavirus Virus-Like Particles Induce Plasmodium Antigen-Specific CD8+ T Cell and Antibody Responses

(2019) David J. Pattinson et al.   Frontiers in Cellular and Infection Microbiology

Novel Plasmodium antigens identified via genome-based antibody screen induce protection associated with polyfunctional T cell responses

(2017) Sophie Schussek et al.   Scientific Reports

Seven-Year Efficacy of RTS,S/AS01 Malaria Vaccine among Young African Children

(2016) Ally Olotu et al.   NEW ENGLAND JOURNAL OF MEDICINE

Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial

(2015)   LANCET

Non-Carrier Nanoparticles Adjuvant Modular Protein Vaccine in a Particle-Dependent Manner

(2015) Arjun Seth et al.   PLoS One

The economics of virus-like particle and capsomere vaccines

(2014) Yap P. Chuan et al.   BIOCHEMICAL ENGINEERING JOURNAL

Co-administration of non-carrier nanoparticles boosts antigen immune response without requiring protein conjugation

(2014) Nani Wibowo et al.   VACCINE

The Relationship between RTS,S Vaccine-Induced Antibodies, CD4+ T Cell Responses and Protection against Plasmodium falciparum Infection

(2013) Michael T. White et al.   PLoS One

Self-adjuvanting modular virus-like particles for mucosal vaccination against group A streptococcus (GAS)

(2013) Tania Rivera-Hernandez et al.   VACCINE

Chimeric SV40 virus-like particles induce specific cytotoxicity and protective immunity against influenza A virus without the need of adjuvants

(2013) Masaaki Kawano et al.   VIROLOGY

IgG Subclass and Heavy Chain Domains Contribute to Binding and Protection by mAbs to the Poly γ-D-glutamic Acid Capsular Antigen of Bacillus anthracis

(2013) Maria Hovenden et al.   PLoS Pathogens

Increased affinity and solubility of peptides used for direct peptide ELISA on polystyrene surfaces through fusion with a polystyrene-binding peptide tag

(2012) Joshua Kogot et al.   BIOTECHNIQUES

Modular engineering of a microbially-produced viral capsomere vaccine for influenza

(2012) Nani Wibowo et al.   CHEMICAL ENGINEERING SCIENCE

Effects of adjuvants on IgG subclasses elicited by virus-like Particles

(2012) Maria Luisa Visciano et al.   Journal of Translational Medicine

A Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Infants

(2012)   NEW ENGLAND JOURNAL OF MEDICINE

Virus-like particles as a highly efficient vaccine platform: Diversity of targets and production systems and advances in clinical development

(2012) Natasha Kushnir et al.   VACCINE

Superior Neutralizing Antibody Response and Protection in Mice Vaccinated with Heterologous DNA Prime and Virus Like Particle Boost against HPAI H5N1 Virus

(2011) Heng Ding et al.   PLoS One

Antigen-specific CD4 T-cell help rescues exhausted CD8 T cells during chronic viral infection

(2011) R. D. Aubert et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

A microbial platform for rapid and low-cost virus-like particle and capsomere vaccines

(2011) Anton P.J. Middelberg et al.   VACCINE

Induction of insert-specific immune response in mice by hamster polyomavirus VP1 derived virus-like particles carrying LCMV GP33 CTL epitope

(2011) Egle Mazeike et al.   VIRUS RESEARCH

A Research Agenda for Malaria Eradication: Vaccines

(2011)   PLOS MEDICINE

Virus-like particles in vaccine development

(2010) António Roldão et al.   Expert Review of Vaccines

Prime-boost vectored malaria vaccines: Progress and prospects

(2010) Adrian V. S. Hill et al.   Human vaccines & immunotherapeutics

Hepatitis B vaccines: Protective efficacy and therapeutic potential

(2010) M.-L. Michel et al.   PATHOLOGIE BIOLOGIE

Characterization of polystyrene-binding peptides (PS-tags) for site-specific immobilization of proteins

(2009) Yoichi Kumada et al.   JOURNAL OF BIOSCIENCE AND BIOENGINEERING

Quaternary size distribution of soluble aggregates of glutathione-S-transferase-purified viral protein as determined by asymmetrical flow field flow fractionation and dynamic light scattering

(2008) Daniel I. Lipin et al.   JOURNAL OF CHROMATOGRAPHY A

A Direct Comparison of Human Papillomavirus Type 16 L1 Particles Reveals a Lower Immunogenicity of Capsomeres than Viruslike Particles with Respect to the Induced Antibody Response

(2008) N. Thones et al.   JOURNAL OF VIROLOGY

Cellular and Humoral Immunogenicity of Hamster Polyomavirus-Derived Virus-Like Particles Harboring a Mucin 1 Cytotoxic T-Cell Epitope

(2008) David C. Dorn et al.   VIRAL IMMUNOLOGY

Quantitative analysis of virus-like particle size and distribution by field-flow fractionation

(2007) Yap P. Chuan et al.   BIOTECHNOLOGY AND BIOENGINEERING

High-level expression of soluble viral structural protein in Escherichia coli

(2007) Yap P. Chuan et al.   JOURNAL OF BIOTECHNOLOGY